Frida Abel

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Drug resistant epilepsy driven by RHEB gene variants - Current evidence and a novel report of a paedatric case.

Drug resistant epilepsy driven by RHEB gene variants - Current evidence and a novel report of a paedatric case.

Journal: Epilepsy & behavior reports
Published: November 21, 2025

Comprehensive characterization and targeted treatment of a pediatric epithelioid glioblastoma with a rare TRIM24-NTRK2 fusion.

Comprehensive characterization and targeted treatment of a pediatric epithelioid glioblastoma with a rare TRIM24-NTRK2 fusion.

Journal: NPJ precision oncology
Published: June 18, 2025

Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression.

Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression.

Journal: Cancer letters
Published: February 25, 2025

A pilocytic astrocytoma with novel ATG16L1::NTRK2 fusion responsive to larotrectinib: a case report with genomic and functional analysis.

A pilocytic astrocytoma with novel ATG16L1::NTRK2 fusion responsive to larotrectinib: a case report with genomic and functional analysis.

Journal: The oncologist
Published: June 13, 2024

Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors-a nationwide, prospective Swedish study.

Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors-a nationwide, prospective Swedish study.

Journal: The Lancet regional health. Europe
Published: November 20, 2023

Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer.

Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer.

Journal: JCO precision oncology
Published: June 29, 2023

Cytoplasmic HIF-2α as tissue biomarker to identify metastatic sympathetic paraganglioma.

Cytoplasmic HIF-2α as tissue biomarker to identify metastatic sympathetic paraganglioma.

Journal: Scientific reports
Published: March 20, 2023

Novel TPR::ROS1 Fusion Gene Activates MAPK, PI3K and JAK/STAT Signaling in an Infant-type Pediatric Glioma.

Novel TPR::ROS1 Fusion Gene Activates MAPK, PI3K and JAK/STAT Signaling in an Infant-type Pediatric Glioma.

Journal: Cancer genomics & proteomics
Published: June 27, 2022

Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib.

Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib.

Journal: Cancer biology & therapy
Published: April 06, 2021

MYO5B mutations in pheochromocytoma/paraganglioma promote cancer progression.

MYO5B mutations in pheochromocytoma/paraganglioma promote cancer progression.

Journal: PLoS genetics
Published: August 10, 2019

Correction: A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.

Correction: A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.

Journal: PloS one
Published: September 08, 2017

A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.

A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.

Journal: PloS one
Published: July 07, 2016
Showing 1-12 of 18

Last Updated: 09/26/2026